Not found

Ping-Ying Pan, PhD

Associate Director, Center for Immunotherapy Research
Houston Methodist


Publications

Leukocyte immunoglobulin-like receptors in human diseases: An overview of their distribution, function, and potential application for immunotherapies
Zhang, J, Mai, S, Chen, HM, Kang, K, Li, XC, Chen, SH & Pan, PY 2017, Journal of Leukocyte Biology, vol 102, no. 2, pp. 351-360. DOI: 10.1189/jlb.5MR1216-534R

LILRB receptor-mediated regulation of myeloid cell maturation and function
van der Touw, W, Chen, HM, Pan, PY & Chen, SH 2017, Cancer Immunology, Immunotherapy, pp. 1-9. DOI: 10.1007/s00262-017-2023-x

Leukocyte immunoglobulin-like receptors in human diseases: An overview of their distribution, function, and potential application for immunotherapies
Zhang, J, Mai, S, Chen, HM, Kang, K, Li, XC, Chen, SH & Pan, PY 2017, Journal of Leukocyte Biology, vol 102, no. 2, pp. 351-360. DOI: 10.1189/jlb.5MR1216-534R

Myeloid-derived suppressor cells as an immune parameter in patients with concurrent sunitinib and stereotactic body radiotherapy
Chen, HM, Ma, G, Gildener-Leapman, N, Eisenstein, S, Coakley, BA, Ozao, J, Mandeli, J, Divino, C, Schwartz, M, Sung, M, Ferris, R, Kao, J, Wang, LH, Pan, PY, Ko, EC & Chen, SH 2015, Clinical Cancer Research, vol 21, no. 18, pp. 4073-4085. DOI: 10.1158/1078-0432.CCR-14-2742

Myeloid-derived suppressor cells as a vehicle for tumor-specific oncolytic viral therapy
Eisenstein, S, Coakley, BA, Briley-Saebo, K, Ma, G, Chen, HM, Meseck, M, Ward, S, Divino, C, Woo, S, Chen, SH & Pan, PY 2013, Cancer Research, vol 73, no. 16, pp. 5003-5015. DOI: 10.1158/0008-5472.CAN-12-1597

Polarization and reprogramming of myeloid-derived suppressor cells
Yang, WC, Ma, G, Chen, SH & Pan, PY 2013, Journal of Molecular Cell Biology, vol 5, no. 3, pp. 207-209. DOI: 10.1093/jmcb/mjt009

Myeloid-derived suppressor cells as a trojan horse: A cellular vehicle for the delivery of oncolytic viruses
Pan, PY, Chen, HM & Chen, SH 2013, OncoImmunology, vol 2, no. 8, e25083. DOI: 10.4161/onci.25083

Myeloid-derived suppressive cells and their regulatory mechanisms in cancer
Ma, G, Pan, PY & Chen, SH 2012, . in Innate Immune Regulation and Cancer Immunotherapy. Springer New York, pp. 231-250. DOI: 10.1007/9781441999146_13

Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells
Ma, G, Pan, PY, Eisenstein, S, Divino, CM, Lowell, CA, Takai, T & Chen, SH 2011, Immunity, vol 34, no. 3, pp. 385-395. DOI: 10.1016/j.immuni.2011.02.004

Myeloid-derived suppressor cells prevent type 1 diabetes in murine models
Yin, B, Ma, G, Yen, CY, Zhou, Z, Wang, GX, Divino, CM, Casares, S, Chen, SH, Yang, WC & Pan, PY 2010, Journal of Immunology, vol 185, no. 10, pp. 5828-5834. DOI: 10.4049/jimmunol.0903636

Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells
Zhou, Z, French, DL, Ma, G, Eisenstein, S, Chen, Y, Divino, CM, Keller, G, Chen, SH & Pan, PY 2010, Stem Cells, vol 28, no. 3, pp. 620-632. DOI: 10.1002/stem.301

Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer
Pan, PY, Ma, G, Weber, KJ, Ozao-Choy, J, Wang, G, Yin, B, Divino, CM & Chen, SH 2010, Cancer Research, vol 70, no. 1, pp. 99-108. DOI: 10.1158/0008-5472.CAN-09-1882

The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies
Ozao-Choy, J, Ge, M, Kao, J, Wang, GX, Meseck, M, Sung, M, Schwartz, M, Divino, CM, Pan, PY & Chen, SH 2009, Cancer Research, vol 69, no. 6, pp. 2514-2522. DOI: 10.1158/0008-5472.CAN-08-4709

Advancements in immune tolerance
Pan, PY, Ozao, J, Zhou, Z & Chen, SH 2008, Advanced Drug Delivery Reviews, vol 60, no. 2, pp. 91-105. DOI: 10.1016/j.addr.2007.08.025

Reversion of immune tolerance in advanced malignancy: Modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
Pan, PY, Wang, GX, Yin, B, Ozao, J, Ku, T, Divino, CM & Chen, SH 2008, Blood, vol 111, no. 1, pp. 219-228. DOI: 10.1182/blood-2007-04-086835

Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
Huang, B, Pan, PY, Li, Q, Sato, AI, Levy, DE, Bromberg, J, Divino, CM & Chen, SH 2006, Cancer Research, vol 66, no. 2, pp. 1123-1131. DOI: 10.1158/0008-5472.CAN-05-1299

NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation
Xu, D, Gu, P, Pan, PY, Li, Q, Sato, AI & Chen, SH 2004, International Journal of Cancer, vol 109, no. 4, pp. 499-506. DOI: 10.1002/ijc.11696

Regulation of Dendritic Cell Function by NK Cells: Mechanisms Underlying the Synergism in the Combination Therapy of IL-12 and 4-1BB Activation
Pan, PY, Gu, P, Li, Q, Xu, D, Weber, K & Chen, SH 2004, Journal of Immunology, vol 172, no. 8, pp. 4779-4789.

Role of Immature Myeloid Gr-1+ Cells in the Development of Antitumor Immunity
Li, Q, Pan, PY, Gu, P, Xu, D & Chen, SH 2004, Cancer Research, vol 64, no. 3, pp. 1130-1139. DOI: 10.1158/0008-5472.CAN-03-1715

In situ recruitment of antigen-presenting cells by intratumoral GM-CSF gene delivery
Pan, PY, Li, Y, Li, Q, Gu, P, Martinet, O, Thung, S & Chen, SH 2004, Cancer Immunology, Immunotherapy, vol 53, no. 1, pp. 17-25. DOI: 10.1007/s00262-003-0417-4